Latest Insider Transactions at Hanover Bancorp, Inc. (HNVR)
This section provides a real-time view of insider transactions for Hanover Bancorp, Inc. (HNVR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hanover Bancorp, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hanover Bancorp, Inc. 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2024
|
Michael David M.D. Katz Director |
SELL
Open market or private sale
|
Direct |
5,000
-3.24%
|
$125,000
$25.53 P/Share
|
|
Dec 10
2024
|
Robert Golden Director |
SELL
Open market or private sale
|
Direct |
2,500
-8.11%
|
$62,500
$25.5 P/Share
|
|
Dec 01
2024
|
Joseph F Burns EVP & Chief Lending Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
576
-7.2%
|
$14,400
$25.19 P/Share
|
|
Dec 01
2024
|
John P Vivona FSVP & Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-6.75%
|
$5,400
$25.19 P/Share
|
|
Nov 22
2024
|
Elena Sisti Director |
BUY
Open market or private purchase
|
Direct |
215
+0.21%
|
$4,945
$23.48 P/Share
|
|
Sep 10
2024
|
Varkey Abraham Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,217
+7.0%
|
$32,170
$10.0 P/Share
|
|
Aug 28
2024
|
Michael P Puorro Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
49,974
-7.78%
|
$849,558
$17.75 P/Share
|
|
Aug 28
2024
|
Michael P Puorro Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
71,840
+10.05%
|
$718,400
$10.0 P/Share
|
|
Aug 26
2024
|
Ahron H Haspel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,650
-15.12%
|
$8,137,500
$1750.0 P/Share
|
|
Aug 26
2024
|
Ahron H Haspel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,139
+20.92%
|
$81,390
$10.0 P/Share
|
|
Aug 20
2024
|
Philip A Okun Director |
BUY
Open market or private purchase
|
Direct |
100
+0.25%
|
$1,700
$17.14 P/Share
|
|
Aug 01
2024
|
Lance P Burke EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
540
-2.46%
|
$9,180
$17.61 P/Share
|
|
Jun 14
2024
|
Philip A Okun Director |
BUY
Open market or private purchase
|
Direct |
500
+1.25%
|
$8,000
$16.49 P/Share
|
|
Jun 13
2024
|
Philip A Okun Director |
BUY
Open market or private purchase
|
Direct |
500
+1.26%
|
$8,000
$16.47 P/Share
|
|
Jun 12
2024
|
Philip A Okun Director |
BUY
Open market or private purchase
|
Direct |
500
+1.28%
|
$8,000
$16.25 P/Share
|
|
Jun 11
2024
|
Philip A Okun Director |
BUY
Open market or private purchase
|
Direct |
500
+1.29%
|
$8,000
$16.26 P/Share
|
|
May 03
2024
|
Lance P Burke EVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
175
+0.79%
|
$2,800
$16.61 P/Share
|
|
May 02
2024
|
Lance P Burke EVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
200
+0.91%
|
$3,200
$16.57 P/Share
|
|
May 01
2024
|
Lance P Burke EVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
200
+0.92%
|
$3,200
$16.67 P/Share
|
|
Apr 30
2024
|
Mc Clelland W Wilcox President |
BUY
Open market or private purchase
|
Direct |
250
+0.31%
|
$4,000
$16.6 P/Share
|
|
Apr 30
2024
|
Michael P Puorro Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.18%
|
$8,000
$16.6 P/Share
|
|
Apr 30
2024
|
Lance P Burke EVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
200
+0.93%
|
$3,200
$16.6 P/Share
|
|
Apr 24
2024
|
Lance P Burke EVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
200
+0.94%
|
$3,200
$16.78 P/Share
|
|
Apr 24
2024
|
John P Vivona FSVP & Chief Risk Officer |
BUY
Open market or private purchase
|
Direct |
200
+5.88%
|
$3,200
$16.79 P/Share
|
|
Apr 24
2024
|
Michael P Puorro Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
200
+0.07%
|
$3,200
$16.78 P/Share
|
|
Apr 23
2024
|
Michael P Puorro Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
200
+0.07%
|
$3,200
$16.9 P/Share
|
|
Apr 22
2024
|
Elena Sisti Director |
BUY
Open market or private purchase
|
Direct |
2,000
+1.93%
|
$32,000
$16.95 P/Share
|
|
Apr 22
2024
|
Mc Clelland W Wilcox President |
BUY
Open market or private purchase
|
Direct |
200
+0.25%
|
$3,200
$16.91 P/Share
|
|
Apr 22
2024
|
Michael P Puorro Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
200
+0.07%
|
$3,200
$16.58 P/Share
|
|
Apr 09
2024
|
Michael David M.D. Katz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,057
+4.37%
|
$70,570
$10.0 P/Share
|
|
Mar 05
2024
|
Philip A Okun Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,938
-11.6%
|
$79,008
$16.48 P/Share
|
|
Mar 05
2024
|
Philip A Okun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,139
+16.05%
|
$81,390
$10.0 P/Share
|
|
Mar 01
2024
|
Metin Negrin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+0.89%
|
-
|
|
Mar 01
2024
|
Philip A Okun Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+5.79%
|
-
|
|
Mar 01
2024
|
Varkey Abraham Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+5.08%
|
-
|
|
Mar 01
2024
|
Robert Golden Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+6.42%
|
-
|
|
Mar 01
2024
|
Elena Sisti Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+2.08%
|
-
|
|
Mar 01
2024
|
Michael David M.D. Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+1.42%
|
-
|
|
Mar 01
2024
|
Ahron H Haspel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+8.56%
|
-
|
|
Mar 01
2024
|
John R Sorrenti Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+4.56%
|
-
|
|
Feb 20
2024
|
Lance P Burke EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,040
-2.38%
|
$17,680
$17.6 P/Share
|
|
Feb 20
2024
|
Mc Clelland W Wilcox President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,974
-1.78%
|
$50,558
$17.6 P/Share
|
|
Feb 20
2024
|
Lisa A Diiorio FSVP & Chief Accounting Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
428
-2.79%
|
$7,276
$17.6 P/Share
|
|
Jan 31
2024
|
Robert Golden Director |
BUY
Open market or private purchase
|
Direct |
500
+1.71%
|
$9,000
$18.0 P/Share
|
|
Jan 29
2024
|
Elena Sisti Director |
BUY
Open market or private purchase
|
Direct |
2,750
+2.74%
|
$49,500
$18.01 P/Share
|
|
Jan 29
2024
|
Michael David M.D. Katz Director |
BUY
Open market or private purchase
|
Direct |
700
+0.48%
|
$12,600
$18.02 P/Share
|
|
Jan 19
2024
|
Lisa A Diiorio FSVP & Chief Accounting Off. |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+6.13%
|
-
|
|
Jan 19
2024
|
Lance P Burke EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+11.32%
|
-
|
|
Jan 19
2024
|
Mc Clelland W Wilcox President |
BUY
Grant, award, or other acquisition
|
Direct |
7,745
+8.44%
|
-
|
|
Jan 19
2024
|
Kevin Corbett EVP & Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+10.63%
|
-
|